HL 538
Alternative Names: HL-538Latest Information Update: 01 Dec 2023
At a glance
- Originator Kechow Pharma
- Class Antineoplastics; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Solid tumours
Most Recent Events
- 09 Oct 2023 Early research in Solid tumours in China (unspecified route) (Kechow Pharma pipeline, October 2023)